Third Arc Bio
Lower Gwynedd Township, Pennsylvania, United States · Biotechnology · 200 employees
Third Arc Bio's mission is to deliver transformational therapies for solid tumors and I&I diseases in the form of multifunctional antibodies that create immune synapses to precisely activate or inhibit T cells. We have a world class team with a proven track record of success, which positions us well to advance the next generation of highly innovative medicines that redefine the standard-of-care
Funding history
- Series series a — $52.0M — Feb 2026
- Funding Round — $72.5M — Aug 2024
Recent signals
- Feb 04, 2026: Raised $52.0M in Series series a
- Aug 01, 2024: Raised $72.5M
See plans & pricing → Track Third Arc Bio’s funding, hiring, and signals — with verified contacts — on Fundz.